170 related articles for article (PubMed ID: 17726151)
1. A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein.
Eriksson J; Woschnagg C; Fernvik E; Venge P
J Leukoc Biol; 2007 Dec; 82(6):1491-500. PubMed ID: 17726151
[TBL] [Abstract][Full Text] [Related]
2. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications.
Trulson A; Byström J; Engström A; Larsson R; Venge P
Clin Exp Allergy; 2007 Feb; 37(2):208-18. PubMed ID: 17250693
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil cationic protein (ECP) is processed during secretion.
Woschnagg C; Rubin J; Venge P
J Immunol; 2009 Sep; 183(6):3949-54. PubMed ID: 19692640
[TBL] [Abstract][Full Text] [Related]
4. Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP).
Rubin J; Venge P
Mol Immunol; 2013 Oct; 55(3-4):372-80. PubMed ID: 23597768
[TBL] [Abstract][Full Text] [Related]
5. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity.
Rubin J; Zagai U; Blom K; Trulson A; Engström A; Venge P
J Immunol; 2009 Jul; 183(1):445-51. PubMed ID: 19542456
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of human eosinophil cationic protein by an epitope-specific antibody.
Boix E; Carreras E; Nikolovski Z; Cuchillo CM; Nogués MV
J Leukoc Biol; 2001 Jun; 69(6):1027-35. PubMed ID: 11404391
[TBL] [Abstract][Full Text] [Related]
7. Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines.
Glimelius I; Rubin J; Fischer M; Molin D; Amini RM; Venge P; Enblad G
Exp Hematol; 2011 Aug; 39(8):850-8. PubMed ID: 21679745
[TBL] [Abstract][Full Text] [Related]
8. A platform for high-throughput molecular characterization of recombinant monoclonal antibodies.
Bailey MJ; Hooker AD; Adams CS; Zhang S; James DC
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):177-87. PubMed ID: 16174568
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry.
Keykhosravani M; Doherty-Kirby A; Zhang C; Brewer D; Goldberg HA; Hunter GK; Lajoie G
Biochemistry; 2005 May; 44(18):6990-7003. PubMed ID: 15865444
[TBL] [Abstract][Full Text] [Related]
10. A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP.
Jönsson UB; Byström J; Stålenheim G; Venge P
J Leukoc Biol; 2006 Apr; 79(4):846-51. PubMed ID: 16434694
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and characterization of monoclonal antibody against human carboxylesterases-II].
Wu ZH; Tang XB; Wang ZG; Ji HY; Yu L; Liu HW; Zhu DL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):148-51. PubMed ID: 17286910
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function.
Antes B; Amon S; Rizzi A; Wiederkum S; Kainer M; Szolar O; Fido M; Kircheis R; Nechansky A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):250-6. PubMed ID: 17296336
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening of packed-bed chromatography coupled with SELDI-TOF MS analysis: monoclonal antibodies versus host cell protein.
Wierling PS; Bogumil R; Knieps-Grünhagen E; Hubbuch J
Biotechnol Bioeng; 2007 Oct; 98(2):440-50. PubMed ID: 17335062
[TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modifications on proteins: facile and efficient procedure for the identification of O-glycosylation sites by MALDI-LIFT-TOF/TOF mass spectrometry.
Kurogochi M; Matsushita T; Nishimura S
Angew Chem Int Ed Engl; 2004 Aug; 43(31):4071-5. PubMed ID: 15300698
[No Abstract] [Full Text] [Related]
16. Spider egg case core fibers: trimeric complexes assembled from TuSp1, ECP-1, and ECP-2.
Hu X; Kohler K; Falick AM; Moore AM; Jones PR; Vierra C
Biochemistry; 2006 Mar; 45(11):3506-16. PubMed ID: 16533031
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
18. Efficient monitoring of enzymatic conjugation reaction by surface-enhanced laser desorption/ionization time of flight mass spectrometry for process optimization.
Freire T; D'Alayer J; Bay S
Bioconjug Chem; 2006; 17(2):559-64. PubMed ID: 16536491
[TBL] [Abstract][Full Text] [Related]
19. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
[TBL] [Abstract][Full Text] [Related]
20. A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies.
Siemiatkoski J; Lyubarskaya Y; Houde D; Tep S; Mhatre R
Carbohydr Res; 2006 Feb; 341(3):410-9. PubMed ID: 16378604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
